Lina Li | Associate Director, IR |
John Leonard | President, CEO & Director |
Laura Sepp-Lorenzino | EVP & Chief Scientific Officer |
Glenn Goddard | EVP & CFO |
Maurice Raycroft | Jefferies |
David Allen | Barclays |
Mani Foroohar | SVB Leerink |
Madhu Kumar | Robert W. Baird & Co. |
Steven Seedhouse | Raymond James & Associates |
Max Smock | BTIG |
Silvan Tuerkcan | Oppenheimer |
Good morning. My name is Andrew, and I will be your conference operator today, and welcome to the Intellia Therapeutics Fourth Quarter and Full Year 2019 Financial Results Conference Call. [Operator Instructions].
At this time, I would like to turn it over to Lina Li, Associate Director of Investor Relations at Intellia. Please proceed.